Phase III trials examining the efficacy of cetirizine ophthalmic solution 0.24% compared to vehicle for the treatment of allergic conjunctivitis in the conjunctival allergen challenge model

PURPOSE: The purpose of these Phase III studies was to evaluate the efficacy and safety of cetirizine ophthalmic solution 0.24% compared with vehicle in the treatment of allergen-induced conjunctivitis using the Ora conjunctival allergen challenge (CAC)(®) model. METHODS: The single-center (Study 1)...

Descripción completa

Detalles Bibliográficos
Autores principales: Meier, Edward J, Torkildsen, Gail L, Gomes, Paul J, Jasek, Mark C
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2018
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6296187/
https://www.ncbi.nlm.nih.gov/pubmed/30587908
http://dx.doi.org/10.2147/OPTH.S185835

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6296187/
https://www.ncbi.nlm.nih.gov/pubmed/30587908
http://dx.doi.org/10.2147/OPTH.S185835

Ejemplares similares